Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 13/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL390826 | 1.00 | MC4R (0.54) | MC4RKEAP1CYP3A4GAAMAPK1 | |
| SCHEMBL17871701 | 1.00 | MC4R (0.54) | MC4RKEAP1CYP3A4GAAMAPK1 | |
| SCHEMBL31388217 | 1.00 | MC4R (0.54) | MC4RKEAP1CYP3A4GAAMAPK1 | |
| SCHEMBL31128130 | 1.00 | MC4R (0.54) | MC4RKEAP1CYP3A4GAAMAPK1 | |
| SCHEMBL442668 | 1.00 | MC4R (0.54) | MC4RKEAP1CYP3A4GAAMAPK1 | |
| Hydrochloric Acid SCHEMBL17871800 | 0.98 | MC4R (0.53) | MC4RKEAP1CYP3A4GAAMAPK1 | |
| SCHEMBL5792053 | 0.98 | MC4R (0.55) | MC4RKEAP1CYP3A4GAAKCNQ2 | |
| Methylene Chloride SCHEMBL27881490 | 0.95 | MC4R (0.54) | MC4RKEAP1CYP3A4GAA | |
| SCHEMBL19665213 | 0.88 | KEAP1 (0.45) | MC4RKEAP1GAAMAPK1KCNQ2 | |
| Glutarate SCHEMBL2343643 | 0.87 | MC4R (0.53) | MC4RCYP3A4GAAKCNQ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2364977-A1 | Process for the enantiomeric enrichment of 3-methyl-1-(2-piperidinophenyl)-1-butylamine | Reuter Chemische Apparatebau KG (DE) | 2011-09-14 | — | — | EP | disclosed |
| EP-2358369-A1 | Process for the preparation of substantially optically pure repaglinide and precursors thereof | Krka Tovarna Zdravil, D.D., Novo Mesto (SI) | 2011-08-24 | — | — | EP | disclosed |
| EP-2344466-A1 | 2-ETHOXY BENZOIC ACID DERIVATIVE | STADA ARZNEIMITTEL AG (DE) | 2011-07-20 | — | — | EP | disclosed |
| EP-2334659-A2 | PHENYL MALONIC ACID DERIVATIVES | STADA ARZNEIMITTEL AG (DE) | 2011-06-22 | — | — | EP | disclosed |
| WO-2010046360-A1 | PROCESS FOR THE PREPARATION OF SUBSTANTIALLY OPTICALLY PURE REPAGLINIDE AND PRECURSORS THEREOF | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) | 2010-04-29 | — | — | WO | disclosed |
| EP-2177221-A1 | Process for the preparation of substantially optically pure Repaglinide and precursors thereof | Krka Tovarna Zdravil, D.D., Novo Mesto (SI) | 2010-04-21 | — | — | EP | disclosed |
| WO-2010028840-A1 | 2-ETHOXY BENZOIC ACID DERIVATIVE | STADA ARZNEIMITTEL AG (DE) | 2010-03-18 | — | — | WO | disclosed |
| WO-2010028842-A2 | PHENYL MALONIC ACID DERIVATIVES | STADA ARZNEIMITTEL AG (DE) | 2010-03-18 | — | — | WO | disclosed |